1 Jones PA, "The epigenomics of cancer" 128 : 683-692, 2007
2 Manna SK, "Suppression of tumor necrosis factor-activated nuclear transcription factor-kappaB, activator protein-1, c-Jun N-terminal kinase, and apoptosis by beta-lapachone" 57 : 763-774, 1999
3 Sah NK, "Structural, functional and therapeutic biology of survivin" 244 : 164-171, 2006
4 Dorai T, "Role of chemopreventive agents in cancer therapy" 215 : 129-140, 2004
5 Karin M, "Receptor-mediated endocytosis of transferrin in developmentally totipotent mouse teratocarcinoma stem cells" 256 : 3245-3252, 1981
6 Cui Y, "Reactivation of methylation-silenced tumor suppressor gene p16INK4a by nordihydroguaiaretic acid and its implication in G1 cell cycle arrest" 82 : 247-255, 2008
7 Orlikova B, "Power from the garden : plant compounds as inhibitors of the hallmarks of cancer" 19 : 2061-2087, 2012
8 Li W, "PKM2 inhibitor shikonin suppresses TPA-induced mitochondrial malfunction and proliferation of skin epidermal JB6 cells" 2012
9 Lai H, "Oral artemisinin prevents and delays the development of 7, 12-dimethylbenz[a]anthracene(DMBA)-induced breast cancer in the rat" 231 : 43-48, 2006
10 Warburg O, "On the origin of cancer cells" 123 : 309-314, 1956
1 Jones PA, "The epigenomics of cancer" 128 : 683-692, 2007
2 Manna SK, "Suppression of tumor necrosis factor-activated nuclear transcription factor-kappaB, activator protein-1, c-Jun N-terminal kinase, and apoptosis by beta-lapachone" 57 : 763-774, 1999
3 Sah NK, "Structural, functional and therapeutic biology of survivin" 244 : 164-171, 2006
4 Dorai T, "Role of chemopreventive agents in cancer therapy" 215 : 129-140, 2004
5 Karin M, "Receptor-mediated endocytosis of transferrin in developmentally totipotent mouse teratocarcinoma stem cells" 256 : 3245-3252, 1981
6 Cui Y, "Reactivation of methylation-silenced tumor suppressor gene p16INK4a by nordihydroguaiaretic acid and its implication in G1 cell cycle arrest" 82 : 247-255, 2008
7 Orlikova B, "Power from the garden : plant compounds as inhibitors of the hallmarks of cancer" 19 : 2061-2087, 2012
8 Li W, "PKM2 inhibitor shikonin suppresses TPA-induced mitochondrial malfunction and proliferation of skin epidermal JB6 cells" 2012
9 Lai H, "Oral artemisinin prevents and delays the development of 7, 12-dimethylbenz[a]anthracene(DMBA)-induced breast cancer in the rat" 231 : 43-48, 2006
10 Warburg O, "On the origin of cancer cells" 123 : 309-314, 1956
11 Newman DJ, "Natural products as sources of new drugs over the 30 years from 1981 to 2010" 75 : 311-335, 2012
12 Nobili S, "Natural compounds for cancer treatment and prevention" 59 : 365-378, 2009
13 Folmer F, "Marine natural products targeting phospholipases A2" 80 : 1793-1800, 2010
14 Schumacher M, "Gold from the sea : marine compounds as inhibitors of the hallmarks of cancer" 29 : 531-547, 2011
15 Ramawat K, "Drugs: Ethnomedicine to Modern Medicine" Springer 153-171, 2009
16 Aviello G, "Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer" 90 : 925-934, 2012
17 Wu X, "Chemoprevention--history and general principles" 25 : 445-459, 2011
18 Sawadogo WR, "A survey of marine natural compounds and their derivatives with anti-cancer activity reported in 2011" 18 : 3641-3673, 2013
19 Dias DA, "A historical overview of natural products in drug discovery" 2 : 303-336, 2012
20 Fearon ER, "A genetic model for colorectal tumorigenesis" 61 : 759-767, 1990
21 Byun HM, "2’-Deoxy-N4-[2-(4-nitrophenyl)ethoxycarbonyl]-5-azacytidine : a novel inhibitor of DNA methyltransferase that requires activation by human carboxylesterase 1" 266 : 238-248, 2008